GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stageBrady Park, Subodh Verma, Ehab Bakbak et al.|American Journal of Physiology-Heart and Circulatory Physiology|2024Cited by 98
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetesBrady Park, Subodh Verma, Aishwarya Krishnaraj et al.|American Journal of Physiology-Heart and Circulatory Physiology|2024Cited by 17
Semaglutide promotes bone marrow–derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trialBrady Park, Subodh Verma, Arianna Z He et al.|European Heart Journal|2025Cited by 8
Vascular regenerative cells in cardiometabolic diseaseEhab Bakbak, David A. Hess, Aishwarya Krishnaraj et al.|Current Opinion in Cardiology|2023Cited by 7
Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trialEhab Bakbak, Subodh Verma, Aishwarya Krishnaraj et al.|Med|2024Cited by 6